Related Experiment Video
Updated: May 23, 2026
Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
MiR-34a inhibits lipopolysaccharide-induced inflammatory response through targeting Notch1 in murine macrophages
Pei Jiang1, Ronghua Liu, Yijie Zheng
1Department of Immunology, Shanghai Medical College, Key Laboratory of Molecular Medicine of Ministry of Education, Fudan University, Shanghai, People's Republic of China.
Abstract:
Inflammatory responses are complex events occurring when the host immune system fights against invading pathogens, which are double-edged swords requiring appropriate control. MicroRNAs (miRNAs), emerging as a new layer of gene-regulation mechanism, have been reported to have crucial effects on inflammation. In the current study, we identified miR-34a, previously known for its potent tumor suppressive role, to be a novel inflammation regulator. We found that the expression of miR-34a was downregulated in macrophages after lipopolysaccharide (LPS) stimulation. MiR-34a mimics decreased, while the inhibition of miR-34a increased, the expression of inflammatory cytokines tumor necrosis factor-
Insights
MicroRNA-34a (miR-34a) acts as a novel inflammation regulator. This study shows miR-34a suppresses inflammatory responses by targeting Notch1, offering potential for new anti-inflammatory drug development.
Area of Science:
- Molecular Biology
- Immunology
- Gene Regulation
Background:
- Inflammation is a critical immune response requiring precise regulation.
- MicroRNAs (miRNAs) are key regulators of gene expression with known roles in inflammation.
- miR-34a, typically known as a tumor suppressor, is investigated for its role in inflammation.
Purpose of the Study:
- To identify novel regulators of inflammation.
- To investigate the role of miR-34a in lipopolysaccharide (LPS)-induced inflammation.
- To elucidate the molecular mechanism of miR-34a in regulating inflammatory responses.
Main Methods:
- Macrophage cell culture (RAW264.7) and LPS stimulation.
- Quantitative real-time PCR and Western blotting to assess gene and protein expression.
- Luciferase reporter assay to confirm miRNA-target interaction.
- Inhibition of Notch1 using genetic and pharmacological approaches.
Main Results:
- miR-34a expression was downregulated in LPS-stimulated macrophages.
- Overexpression of miR-34a reduced inflammatory cytokines (TNF-α, IL-6); inhibition increased them.
- miR-34a directly targets Notch1, downregulating its mRNA and protein levels.
- Notch1 inhibition mimicked miR-34a's anti-inflammatory effects.
- miR-34a suppressed NF-κB activation in response to LPS.
Conclusions:
- miR-34a is identified as a novel negative regulator of LPS-induced inflammation.
- The anti-inflammatory effect of miR-34a is mediated, at least partially, through targeting Notch1.
- miR-34a represents a potential therapeutic target for developing new anti-inflammatory drugs.
